Chemical formula: C₂₆H₃₇N₅O₂ Molecular mass: 451.604 g/mol PubChem compound: 54746
Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G02CB03 | Cabergoline | G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors |
| N04BC06 | Cabergoline | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOSTINEX Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Cabergoline is an active ingredient of these brands:
Croatia (HR)Cyprus (CY)Ecuador (EC)Estonia (EE)France (FR)Hong Kong (HK)Japan (JP)Lithuania (LT)Malta (MT)Mexico (MX)Netherlands (NL)New Zealand (NZ)Nigeria (NG)Poland (PL)Romania (RO)Singapore (SG)South Africa (ZA)Tunisia (TN)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
